Moderna shares soar over 50% on melanoma drug trial success
Moderna shares, identified by the ticker $MRNA, soared over 50% following reported success in a melanoma drug trial. The post also included the $MRK ticker and links to two social-media posts.
本网站上的信息是使用AI生成的，我们无法保证其准确性。
请仅作为参考信息使用。
Moderna shares soar over 50% on melanoma drug trial success - CoinPost Terminal